AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,550,720 | +72.7% | 292,000 | +78.4% | 0.06% | +48.6% |
| Q2 2023 | $2,056,235 | -33.8% | 163,713 | -41.5% | 0.04% | -38.3% |
| Q1 2023 | $3,105,200 | +27.2% | 280,000 | +40.0% | 0.06% | +57.9% |
| Q4 2022 | $2,442,000 | +599.7% | 200,000 | +498.8% | 0.04% | +660.0% |
| Q3 2022 | $349,000 | -89.8% | 33,400 | -89.5% | 0.01% | -89.4% |
| Q2 2022 | $3,427,000 | -40.2% | 319,100 | -35.7% | 0.05% | -26.6% |
| Q4 2021 | $5,734,000 | +13.3% | 496,400 | -6.3% | 0.06% | +10.3% |
| Q3 2021 | $5,062,000 | -24.8% | 530,000 | -24.1% | 0.06% | -34.1% |
| Q2 2021 | $6,732,000 | -29.4% | 698,561 | -27.6% | 0.09% | -57.1% |
| Q1 2021 | $9,534,000 | -65.6% | 964,900 | -19.5% | 0.20% | -67.5% |
| Q4 2020 | $27,676,000 | +219.4% | 1,198,654 | +95.3% | 0.63% | +210.8% |
| Q3 2020 | $8,666,000 | +123.7% | 613,800 | +139.0% | 0.20% | +57.4% |
| Q2 2020 | $3,874,000 | +329.0% | 256,826 | +162.9% | 0.13% | +152.9% |
| Q1 2020 | $903,000 | +105.7% | 97,700 | +77.6% | 0.05% | +131.8% |
| Q3 2019 | $439,000 | -43.6% | 55,000 | -12.0% | 0.02% | -45.0% |
| Q2 2019 | $779,000 | +13.1% | 62,500 | +23.5% | 0.04% | +5.3% |
| Q1 2019 | $689,000 | -58.4% | 50,600 | -54.0% | 0.04% | -83.8% |
| Q1 2018 | $1,655,000 | +15.0% | 110,000 | +10.0% | 0.24% | +57.7% |
| Q4 2017 | $1,439,000 | – | 100,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |